£84.67

Springer Amlodipine

Price data last checked 23 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£85 today · all-time low £85 (Apr 2026) · usually £85

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 68 days · 68 data points (no recent data)

Historical
Generating forecast…
£89.59 £84.13 £85.32 £86.51 £87.71 £88.90 £90.09 26 April 2026 12 May 2026 29 May 2026 15 June 2026 02 July 2026

Price Distribution

Price distribution over 68 days • 2 price levels

Days at Price
Current Price
40 days · current 28 days 0 10 20 30 40 £85 £90 Days at Price

Price Analysis

Most common price: £85 (40 days, 58.8%)

Price range: £85 - £90

Price levels: 2 different prices over 68 days

Description

"Those who choose to increase their knowledge still further by reading ... will discover an exciting new world. " NOEL WHITTAKER, in "Making Money Made Simple" 1989. The development of calcium antagonists has recently been described as representing "one of the major advances in cardiovascular thera peutics of the latter half of the twentieth century" (Braunwald, 1990). However, although the development of these drugs started in the mid nineteen sixties it is only recently that their real potential has begun to be appreciated. Even now the calcium antagonist saga is not complete, since new compounds continue to appear and new therapeutic applica tions emerge. Based on the experience gained in the clinics in which these drugs have been used recognition is being given now to the need to improve upon the prototypes of the group. Such improvement is resulting in the development and production not only of long-acting formulations of the prototypes (nifedipine, verapamil and diltiazem) but also of new calcium antagonists with improved tissue selectivity, potency and duration of action. To those of us who are interested in this field such a development is both exciting and rewarding. As far as the clinicians who prescribe these drugs are concerned the long-acting nature of some of the newer calcium antagonists should make the satisfactory management of their patients an achievable goal.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 September 1993
Listed Since
04 January 2007

Barcode

No barcode data available

Similar Products You Might Like

Springer Pharmacology of Antihypertensive Therapeutics Book
96% match

Springer Pharmacology of Antihypertensive Therapeutics Book

Springer

£109.18 20 Jul 2026
Treatment with Gallopamil: Results of recent research on calcium antagonism
96% match

Treatment with Gallopamil: Results of recent research on calcium antagonism

Springer

£77.53 04 Jul 2026
Wege zu neuen Arzneimitteln: Geschichte der Hochdruckforschung bei Bayer
96% match

Wege zu neuen Arzneimitteln: Geschichte der Hochdruckforschung bei Bayer

Springer

£57.60 01 Jul 2026
ACE Inhibitors (Milestones in Drug Therapy)
96% match

ACE Inhibitors (Milestones in Drug Therapy)

Birkhauser

£41.40 29 Jun 2026
Antihypertensive Agents: 39 (Handbook of Experimental Pharmacology, 39)
95% match

Antihypertensive Agents: 39 (Handbook of Experimental Pharmacology, 39)

Springer

£77.59 04 Jul 2026
The Emergence of Drugs which Block Calcium Entry: 6 (Progress in Clinical Biochemistry and Medicine, 6)
95% match

The Emergence of Drugs which Block Calcium Entry: 6 (Progress in Clinical Biochemistry and Medicine, 6)

Springer

£75.23 03 Jul 2026
Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications (Pharmacology Research Safety T) (Pharmacology - Research, Safety Testing and Regulation)
95% match

Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications (Pharmacology Research Safety T) (Pharmacology - Research, Safety Testing and Regulation)

£243.99 04 Jul 2026
Therapie und Prävention mit Kalziumantagonisten: Hypertonie ― Koronare Herzkrankheit ― Arteriosklerose
95% match

Therapie und Prävention mit Kalziumantagonisten: Hypertonie ― Koronare Herzkrankheit ― Arteriosklerose

Springer

£43.02 13 Jul 2026
New Targets for the Treatment of Hypertension and Associated Diseases: Volume 94 (Advances in Pharmacology, Volume 94)
95% match

New Targets for the Treatment of Hypertension and Associated Diseases: Volume 94 (Advances in Pharmacology, Volume 94)

Academic Press

£152.88 30 Jun 2026
Calcium-Antagonisten
95% match

Calcium-Antagonisten

Springer

£46.95 14 Jul 2026
Angiotensin II - Antagonismus: Ein neuer Weg zur Hochdruckbehandlung
95% match

Angiotensin II - Antagonismus: Ein neuer Weg zur Hochdruckbehandlung

Springer

£46.99 08 Jul 2026
Angiotensin II Receptor Blockade Physiological and Clinical Implications: 2 (Progress in Experimental Cardiology)
95% match

Angiotensin II Receptor Blockade Physiological and Clinical Implications: 2 (Progress in Experimental Cardiology)

Springer

£227.73 13 Jul 2026
Angiotensin II Receptor Blockade Physiological and Clinical Implications: 2 (Progress in Experimental Cardiology, 2)
94% match

Angiotensin II Receptor Blockade Physiological and Clinical Implications: 2 (Progress in Experimental Cardiology, 2)

Springer

£246.86 10 Jun 2026
Therapie mit Antihypertensiva
94% match

Therapie mit Antihypertensiva

Springer

£43.09 08 Jul 2026
Atlas of Hypertension (Atlas of Heart Diseases)
94% match

Atlas of Hypertension (Atlas of Heart Diseases)

Springer

£53.82 15 Jul 2026
Calcium: The molecular basis of calcium action in biology and medicine
94% match

Calcium: The molecular basis of calcium action in biology and medicine

Springer

£165.67 24 Jun 2026
Calcium: The molecular basis of calcium action in biology and medicine
94% match

Calcium: The molecular basis of calcium action in biology and medicine

Springer

£177.98 10 Jul 2026
Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Cardiovascular Remodeling: Volume 147 (Progress in Molecular Biology and Translational Science, Volume 147)
94% match

Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Cardiovascular Remodeling: Volume 147 (Progress in Molecular Biology and Translational Science, Volume 147)

Academic Press

£113.75 10 Jul 2026
Hypertension and Heart Failure: Epidemiology, Mechanisms and Treatment (Updates in Hypertension and Cardiovascular Protection)
94% match

Hypertension and Heart Failure: Epidemiology, Mechanisms and Treatment (Updates in Hypertension and Cardiovascular Protection)

Springer

£142.97 16 Jun 2026
Cardiovascular Drug Therapy in the Elderly: 72 (Developments in Cardiovascular Medicine)
94% match

Cardiovascular Drug Therapy in the Elderly: 72 (Developments in Cardiovascular Medicine)

Springer

£165.97 15 Jul 2026
Cardiovascular Drug Therapy in the Elderly: 72 (Developments in Cardiovascular Medicine, 72)
94% match

Cardiovascular Drug Therapy in the Elderly: 72 (Developments in Cardiovascular Medicine, 72)

Springer

£150.83 13 Jul 2026
Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Target Tissues and Therapy (Volume 148) (Progress in Molecular Biology and Translational Science, Volume 148)
94% match

Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Target Tissues and Therapy (Volume 148) (Progress in Molecular Biology and Translational Science, Volume 148)

Academic Press

£99.49 10 Jul 2026
Antihypertensive Drugs
94% match

Antihypertensive Drugs

CRC Press

Price unavailable
Pulmonary Arterial Hypertension & Nifedipine
94% match

Pulmonary Arterial Hypertension & Nifedipine

Nova Science Publishers Inc

£90.58 15 Jul 2026